Table 4.
Types and number of drugs received during the hospitalisation
| Cholecalciferol group | Control group | |||
|---|---|---|---|---|
| n | n=274 | n | n=269 | |
| Drugs prescribed | ||||
| Cholecalciferol, n (%) | 274 | 274 (100.0) | 269 | 0 (0.0) |
| Enoxaparin, n (%) | 270 | 210 (77.8) | 264 | 191 (72.3) |
| Ceftriaxone, n (%) | 271 | 100 (36.9) | 264 | 94 (35.6) |
| Methylprednisolone, n (%) | 271 | 99 (36.5) | 265 | 94 (35.5) |
| Azithromycin, n (%) | 272 | 88 (32.4) | 265 | 97 (36.6) |
| Dexamethasone, n (%) | 272 | 83 (30.5) | 265 | 78 (29.4) |
| Number of drugs per patient, median [IQR] | 272 | 2.0 [2.0, 3.0] | 265 | 2.0 [2.0, 3.0] |
The therapies used in less than 10% of patients (hydroxychloroquine N=48, lopinavir, ritonavir N=36, tocilizumab N=25 or plasma from convalescent patients N=53) were not included in the table
n number of patients available for analysis, IQR interquartile range